PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97246521 |
Filing Date: 01/31/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97246521 |
---|---|
MARK INFORMATION | |
*MARK | ALADOTE |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | ALADOTE |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Egetis Therapeutics AB |
*MAILING ADDRESS | Klara Norra Kyrkogata 26 |
*CITY | Stockholm |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Sweden |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
11122 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | aktiebolag (ab) |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED | Sweden |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for the reduction of liver failure |
FILING BASIS | SECTION 44(e) |
FOREIGN REGISTRATION NUMBER |
013431622 |
FOREIGN REGISTRATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
European Union Trademark - EUTM |
FOREIGN REGISTRATION DATE |
03/17/2015 |
FOREIGN REGISTRATION EXPIRATION DATE |
11/04/2024 |
FOREIGN REGISTRATION FILE NAME(S) | |
ORIGINAL PDF FILE | reg-3810515990-093259787_ ._10430319.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\972\465\97246521\xml1\ APP0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\972\465\97246521\xml1\ APP0004.JPG | |
STANDARD CHARACTERS OR EQUIVALENT |
YES |
ATTORNEY INFORMATION | |
NAME | Mark H. Tidman |
ATTORNEY DOCKET NUMBER | 47727.020081 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Baker & Hostetler LLP |
INTERNAL ADDRESS | Washington Square, Suite 1100 |
STREET | 1050 Connecticut Avenue, NW |
CITY | Washington |
STATE | District of Columbia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 20036-5304 |
PHONE | 202-861-1500 |
FAX | 202-861-1783 |
EMAIL ADDRESS | bhipdocket@bakerlaw.com |
OTHER APPOINTED ATTORNEY | Kevin M. Bovard, Gabrial Mitchell, Candice Reder, Lesley McCall Grossberg, Robert B.G. Horowitz, Jacqueline M. Lesser, Nancy Rubner Frandsen, John M. Mueller, Lisa Bollinger Gehman, Deborah A. Wilcox, Kevin M. Wallace |
CORRESPONDENCE INFORMATION | |
NAME | Mark H. Tidman |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | bhipdocket@bakerlaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | mtidman@bakerlaw.com; ahsu@bakerlaw.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Mark H. Tidman/ |
SIGNATORY'S NAME | Mark H. Tidman |
SIGNATORY'S POSITION | Attorney of record, DC bar member |
SIGNATORY'S PHONE NUMBER | 202-861-1500 |
DATE SIGNED | 01/31/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97246521 |
Filing Date: 01/31/2022 |
The applicant's current Correspondence Information: |
Mark H. Tidman |
PRIMARY EMAIL FOR CORRESPONDENCE: bhipdocket@bakerlaw.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): mtidman@bakerlaw.com; ahsu@bakerlaw.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|